{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:13:24Z","timestamp":1789175604276,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40123-024-01087-7","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T12:30:27Z","timestamp":1736944227000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Third-Generation Trabecular Micro-Bypass Implantation with Phacoemulsification for Glaucoma"],"prefix":"10.1007","volume":"14","author":[{"given":"Zachary","family":"Vest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Alinaghizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"12","key":"1087_CR1","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990\u20132020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221\u201334.","journal-title":"Lancet Glob Health"},{"key":"1087_CR2","doi-asserted-by":"crossref","unstructured":"Boland MV, Corcoran KJ, Lee AY. Changes in performance of glaucoma surgeries 1994 through 2017 based on claims and payment data for United States Medicare beneficiaries. Ophthalmol Glaucoma. 2021;4(5):463\u2013471.","DOI":"10.1016\/j.ogla.2021.01.004"},{"issue":"12","key":"1087_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jamaophthalmol.2013.5059","volume":"131","author":"E Rulli","year":"2013","unstructured":"Rulli E, Biagioli E, Riva I, et al. Efficacy and safety of trabeculectomy vs. nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131(12):1573\u201382.","journal-title":"JAMA Ophthalmol"},{"key":"1087_CR4","doi-asserted-by":"crossref","unstructured":"Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153(5):804\u2013814 e1.","DOI":"10.1016\/j.ajo.2011.10.024"},{"issue":"1","key":"1087_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ajo.2005.02.013","volume":"140","author":"HD Jampel","year":"2005","unstructured":"Jampel HD, Musch DC, Gillespie BW, et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140(1):16\u201322.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1087_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archopht.1992.01080200029011","volume":"110","author":"HD Jampel","year":"1992","unstructured":"Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol. 1992;110(8):1049\u201350.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"1087_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ophtha.2011.09.049","volume":"119","author":"HD Jampel","year":"2012","unstructured":"Jampel HD, Solus JF, Tracey PA, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology. 2012;119(4):712\u201322.","journal-title":"Ophthalmology"},{"key":"1087_CR8","first-page":"988","volume":"15","author":"SBC Kamat","year":"2024","unstructured":"Kamat SBC, Shah M, Radcliffe N. Long-term chronic drop therapy vs. intracameral procedural pharmaceuticals for glaucoma: what does the evidence support? J Clin Exp Ophthalmol. 2024;15:988.","journal-title":"J Clin Exp Ophthalmol."},{"key":"1087_CR9","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.2147\/OPTH.S439457","volume":"17","author":"S Bedrood","year":"2023","unstructured":"Bedrood S, Berdahl J, Sheybani A, Singh IP. Alternatives to topical glaucoma medication for glaucoma management. Clin Ophthalmol. 2023;17:3899\u2013913.","journal-title":"Clin Ophthalmol"},{"key":"1087_CR10","first-page":"23","volume":"2024","author":"MSO Gallardo","year":"2024","unstructured":"Gallardo MSO, Trubnik V, Reiss G. Interventional glaucoma and the patient perspective. Expert Rev Ophthalmol. 2024;2024:23.","journal-title":"Expert Rev Ophthalmol"},{"issue":"6","key":"1087_CR11","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s40123-023-00831-9","volume":"12","author":"NM Radcliffe","year":"2023","unstructured":"Radcliffe NM, Shah M, Samuelson TW. Challenging the \u201ctopical medications-first\u201d approach to glaucoma: a treatment paradigm in evolution. Ophthalmol Ther. 2023;12(6):2823\u201339.","journal-title":"Ophthalmol Ther"},{"key":"1087_CR12","doi-asserted-by":"crossref","unstructured":"Micheletti JM, Brink M, Brubaker JW, et al. Standalone interventional glaucoma: an evolution from the combination-cataract paradigm. J Cataract Refract Surg. 2024.","DOI":"10.1097\/j.jcrs.0000000000001537"},{"issue":"2","key":"1087_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ophtha.2008.09.004","volume":"116","author":"CO Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD, et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology. 2009;116(2):191\u20139.","journal-title":"Ophthalmology"},{"issue":"4","key":"1087_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labbe A, Liang H, et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312\u201334.","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"1087_CR15","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Blachley T, Lee PP, et al. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology. 2015;122(10):2010\u201321.","journal-title":"Ophthalmology"},{"issue":"4","key":"1087_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","volume":"127","author":"PA Newman-Casey","year":"2020","unstructured":"Newman-Casey PA, Niziol LM, Gillespie BW, et al. The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology. 2020;127(4):477\u201383.","journal-title":"Ophthalmology"},{"issue":"7","key":"1087_CR17","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308\u201316.","journal-title":"Ophthalmology"},{"key":"1087_CR18","doi-asserted-by":"crossref","unstructured":"Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153(1):1\u20139 e2.","DOI":"10.1016\/j.ajo.2011.05.033"},{"issue":"11 Suppl","key":"1087_CR19","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","volume":"116","author":"JC Tsai","year":"2009","unstructured":"Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11 Suppl):S30\u20136.","journal-title":"Ophthalmology"},{"key":"1087_CR20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/OPTH.S44708","volume":"8","author":"K Inoue","year":"2014","unstructured":"Inoue K. Managing adverse effects of glaucoma medications. Clin Ophthalmol. 2014;8:903\u201313.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"1087_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajo.2007.12.003","volume":"145","author":"J Caprioli","year":"2008","unstructured":"Caprioli J. The importance of rates in glaucoma. Am J Ophthalmol. 2008;145(2):191\u20132.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1087_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IJG.0000000000002141","volume":"32","author":"SR Sarkisian Jr","year":"2023","unstructured":"Sarkisian SR Jr, Grover DS, Gallardo MJ, et al. Effectiveness and safety of iStent infinite trabecular micro-bypass for uncontrolled glaucoma. J Glaucoma. 2023;32(1):9\u201318.","journal-title":"J Glaucoma"},{"issue":"6","key":"1087_CR23","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.ajo.2011.12.017","volume":"153","author":"CK Bahler","year":"2012","unstructured":"Bahler CK, Hann CR, Fjield T, et al. Second-generation trabecular meshwork bypass stent (iStent inject) increases outflow facility in cultured human anterior segments. Am J Ophthalmol. 2012;153(6):1206\u201313.","journal-title":"Am J Ophthalmol"},{"key":"1087_CR24","first-page":"499","volume":"8","author":"KS Hunter","year":"2014","unstructured":"Hunter KS, Fjield T, Heitzmann H, et al. Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling. Clin Ophthalmol. 2014;8:499\u2013506.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"1087_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ophtha.2004.12.026","volume":"112","author":"AL Robin","year":"2005","unstructured":"Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863\u20138.","journal-title":"Ophthalmology"},{"issue":"4","key":"1087_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5301\/EJO.2010.6112","volume":"21","author":"GC Rossi","year":"2011","unstructured":"Rossi GC, Pasinetti GM, Scudeller L, et al. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21(4):410\u20134.","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"1087_CR27","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","volume":"118","author":"B Sleath","year":"2011","unstructured":"Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118(12):2398\u2013402.","journal-title":"Ophthalmology"},{"issue":"6","key":"1087_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"CM Olthoff","year":"2005","unstructured":"Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953\u201361.","journal-title":"Ophthalmology"},{"issue":"2","key":"1087_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0002-9394(14)71282-6","volume":"116","author":"WC Stewart","year":"1993","unstructured":"Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 1993;116(2):176\u201381.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1087_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4):598\u2013606.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1087_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701\u201313 (discussion 829\u201330).","journal-title":"Arch Ophthalmol"},{"key":"1087_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2019.08.008","volume":"207","author":"M Muniesa","year":"2019","unstructured":"Muniesa M, Ezpeleta J, Benitez I. Fluctuations of the intraocular pressure in medically versus surgically treated glaucoma patients by a contact lens sensor. Am J Ophthalmol. 2019;207:429\u201330.","journal-title":"Am J Ophthalmol"},{"key":"1087_CR33","doi-asserted-by":"publisher","first-page":"9890831","DOI":"10.1155\/2019\/9890831","volume":"2019","author":"C Posarelli","year":"2019","unstructured":"Posarelli C, Ortenzio P, Ferreras A, et al. Twenty-four-hour contact lens sensor monitoring of aqueous humor dynamics in surgically or medically treated glaucoma patients. J Ophthalmol. 2019;2019:9890831.","journal-title":"J Ophthalmol"},{"issue":"3","key":"1087_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","volume":"118","author":"TW Samuelson","year":"2011","unstructured":"Samuelson TW, Katz LJ, Wells JM, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459\u201367.","journal-title":"Ophthalmology"},{"issue":"6","key":"1087_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","volume":"126","author":"TW Samuelson","year":"2019","unstructured":"Samuelson TW, Sarkisian SR Jr, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811\u201321.","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01087-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01087-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01087-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:44:06Z","timestamp":1739457846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01087-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1087"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01087-7","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Zachary Vest:  Glaukos- Research support, Consultation; Allergan- Speaker (Surgical Instructor); Ellios- Consultant; Alcon- Research support;  Nadia Alinaghizdeh and Connor Prendergast: nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed were in accordance with the ethical standards of respective clinical sites, the 1964 Helsinki Declaration and its later amendments or comparable ethical standards, and HIPAA privacy standards.  All patients provided informed consent prior to surgery.  No separate ethics approval was required for data analysis (Rocky Vista University IRB, Exemption Approval #2023-298).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}